1. Medtech Insight

Picker International's Outlook magnetic resonance imaging (MRI) system cleared in US

Picker International (US) has received US FDA clearance for its Outlook MRI system which it introduced at last year's Radiology Society of North America (RSNA) meeting (see Clinica No 634, p 18). The 0.23T system's open design offers "unprecedented patient accessibility", says Picker. It features phased-array head, body and surface coils. The faster shielded gradients with 12mT/m peak and 20mT/m/ms rise time allow fast spin echo, magnetisation transfer contrast and 2D and 3D time of flight MR angio.

Picker International (US) has received US FDA clearance for its Outlook MRI system which it introduced at last year's Radiology Society of North America (RSNA) meeting (see Clinica No 634, p 18). The 0.23T system's open design offers "unprecedented patient accessibility", says Picker. It features phased-array head, body and surface coils. The faster shielded gradients with 12mT/m peak and 20mT/m/ms rise time allow fast spin echo, magnetisation transfer contrast and 2D and 3D time of flight MR angio.

Five Outlook systems, which have a price tag of around $900,000, have been installed in the US and Finland, the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight

Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations

 
• By Vibha Sharma

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.

EU Life Sciences Strategy Must Address ‘Regulatory Lasagna’

 
• By Amanda Maxwell

MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”

Questions Over UK Prevention Agenda Within NHS 10-Year Plan

 
• By Ashley Yeo

The UK government’s blueprint to deliver an NHS "fit for the future" was released on July 3.